CD163 and chronic myelogenous leukemia, BCR-ABL1 positive: The previous reports have indicated that the CD68+ macrophages were increasing in BM of CML [21, 22], but the significance of CD163 and CD206 is expressed on BMB samples and it is associated with phases development of CML patients that has not been explored.